Position in ZTS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$24,647
-$232,696 QoQ
Shares Held
343
-84.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,180
of 1,408 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rossby Financial, LCC holds $1,087,397 across 15 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,881 | $1,019,182 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
343 | $24,647 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
85 | $14,325 | |
| 4 | HLN |
Haleon plc
|
885 | $8,257 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
222 | $5,463 | |
| 6 | ALKS |
Alkermes plc.
|
64 | $3,353 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
227 | $3,289 | |
| 8 | VTRS |
Viatris Inc
|
206 | $3,271 |
All Filings in ZTS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,647 | 343 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $257,343 | 2,177 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $258,056 | 2,051 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,113,495 | 7,610 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $914,802 | 5,866 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $734,174 | 4,459 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $592,576 | 3,637 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||